Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05980312 · ClinicalTrials.gov registry record · NA
Does Early Elbow Motion Improve Patient Outcomes After Surgically Treated Elbow Fractures?
A NA study, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05980312: Completed NA study, sponsored by The Cooper Health System.
NCT05980312 is a NA study that has completed, run by The Cooper Health System. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05980312, a NA study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy, defined as improved range of motion and functional outcome scores, of early elbow motion in the early (immediately post-op) and late postoperative periods (2 week post-op).
Primary Outcome
A standardized elbow evaluation was developed by the Research Committee of the American Shoulder and Elbow Surgeons 1 (ASES). This score allows the evaluation of elbow function independently from the underlying diagnosis.
Interventions
- OTHER Splint Immobilization
- OTHER Early Motion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-12-27 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
What the finished NCT05980312 record still lists
NCT05980312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Splint Immobilization is the first listed.
NCT05980312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05980312 about?
NCT05980312 is a clinical study titled "Does Early Elbow Motion Improve Patient Outcomes After Surgically Treated Elbow Fractures?". The purpose of this study is to compare the safety and efficacy, defined as improved range of motion and functional outcome scores, of early elbow motion in the early (immediately post-op) and late postoperative periods (2 week post-op).
What is the current status of trial NCT05980312?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-12-27. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT05980312?
The interventions under investigation include: Splint Immobilization (OTHER), Early Motion (OTHER).
Who is sponsoring clinical trial NCT05980312?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05980312's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI